|
Market Closed -
NSE India S.E.
07:05:07 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 2,475.00 INR | +0.55% |
|
+4.36% | +21.61% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 698B 7.3B 6.41B 6.02B 5.51B 10.29B 10.36B 72.33B 28.01B 356B 27.4B 26.8B 1,155B | P/E 2027 * |
30.1x | P/E 2028 * | 25x |
|---|---|---|---|---|---|
| Enterprise Value | 662B 6.91B 6.07B 5.7B 5.22B 9.75B 9.82B 68.55B 26.55B 338B 25.97B 25.4B 1,095B | EV / Sales 2027 * |
3.94x | EV / Sales 2028 * | 3.48x |
| Free-Float |
51.04% | Yield 2027 * |
0.15% | Yield 2028 * | 0.16% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.55% | ||
| 1 week | +4.36% | ||
| Current month | -0.20% | ||
| 1 month | +6.78% | ||
| 3 months | +12.92% | ||
| 6 months | +13.53% | ||
| Current year | +21.61% |
| 1 week | 2,388.4 |  | 2,482.6 |
| 1 month | 2,295.3 | | 2,537.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 1999-12-31 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 2025-05-26 |
Indrajit Bose
PSD | President | - | 2023-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 2011-05-11 | |
| Director/Board Member | 86 | 2009-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +4.36% | +22.66% | +208.30% | 7.27B | |
| +1.01% | +1.63% | +13.44% | +64.70% | 46.34B | |
| -1.02% | -2.67% | +38.33% | +108.43% | 37.12B | |
| +0.67% | +6.47% | +12.98% | +96.46% | 12.13B | |
| -0.08% | +2.37% | -10.32% | +16.62% | 11.7B | |
| +0.19% | 0.00% | +19.82% | +140.74% | 8.99B | |
| +0.56% | +0.08% | +26.32% | +37.72% | 7.25B | |
| -0.06% | +1.51% | +38.94% | -16.76% | 7.13B | |
| -0.64% | +4.66% | -40.29% | +10.76% | 5.16B | |
| +1.39% | +1.64% | +40.52% | +109.16% | 4.6B | |
| Average | +0.26% | +1.51% | +16.24% | +77.61% | 14.77B | |
| Weighted average by Cap. | +0.19% | +0.73% | +19.45% | +80.43% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.75B 1.54B 1.45B 1.32B 2.47B 2.49B 17.39B 6.74B 85.66B 6.59B 6.44B 278B | 187B 1.95B 1.72B 1.61B 1.48B 2.76B 2.78B 19.38B 7.51B 95.45B 7.34B 7.18B 309B |
| Net income | 23.11B 241M 212M 199M 182M 341M 343M 2.39B 927M 11.79B 907M 887M 38.21B | 27.71B 289M 254M 239M 219M 408M 411M 2.87B 1.11B 14.13B 1.09B 1.06B 45.81B |
| Net Debt | -36.49B -381M -335M -314M -288M -538M -542M -3.78B -1.46B -18.61B -1.43B -1.4B -60.33B | -48B -501M -440M -414M -379M -707M -712M -4.97B -1.93B -24.49B -1.88B -1.84B -79.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | ₹2,475.00 | +0.55% | 597,118 |
| 26-09-22 | ₹2,461.40 | +0.47% | 402,355 |
| 26-09-21 | ₹2,450.00 | +0.11% | 405,696 |
| 26-09-18 | ₹2,447.40 | +1.30% | 545,520 |
| 26-09-17 | ₹2,416.00 | +0.25% | 227,416 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
